Home
Development Programs
For Investors
- ASX Announcements
- Corporate Governance
News
About Us
- Our Name & Brandmark
- Team
Contact

Menu

Home
Development Programs
For Investors
- ASX Announcements
- Corporate Governance
News
About Us
- Our Name & Brandmark
- Team
Contact

General

Program: EMD-RX5

Program: EMD-RX5

Developing a new cannabinoid formulation for stress, anxiety and …

Program: EMD-003

Program: EMD-003

Developing a new cannabinoid formulation for stress, anxiety and …

DEVELOPMENT PROGRAMS

Ultra-Pure CBD Medicines
MDMA-inspired Medicines
Research & Data Programs

Ultra-Pure CBD Medicines
MDMA-inspired Medicines
Research & Data Programs

FOR INVESTORS

Investor Hub
Corporate Governance

Investor Hub
Corporate Governance

RECENT TWEETS

© 2023 Emyria Limited

Terms | Privacy | Website by Glide

Phone
08 6559 2800

Email
info@emyria.com

Linkedin Twitter Youtube

First Name*
Last Name*
Email*
Post code
What news are you interested in?*
- Clinical news
- Patient news
- Investor news
- Partners news
CAPTCHA
Email
This field is for validation purposes and should be left unchanged.

Δ

Search for:

Hit enter to search or ESC to close

Home
Development Programs
For Investors
- ASX Announcements
- Corporate Governance
News
About Us
- Our Name & Brandmark
- Team
Contact

Call 08 6559 2800 Contact